Aemetis, Inc ($AMTX) - buy or sell? Stock discussion, ideas, forum

Aemetis, Inc

Aemetis, Inc.

Industry: Oil & Gas Refining & Marketing

Ticker	Exchange	ISIN
$AMTX	Nasdaq	US00770K2024

Recent news

Synacor, Inc. reports 33.2% revenue decline in FY2020

BSQUARE Corporation reports 20.5% revenue decline in 2020 and 11.3 pp EBITDA Margin growth from -12.5% to -1.2%

eMagin Corporation CAPEX surged on 125% and Revenue jumped on 10.1%

Viveve Medical, Inc. reports 28.2% CAPEX decline in 2020 and 16.6% Revenue decline

Canadian Solar Inc. Debt jumped on 22.2% and Revenue increased on 8.6%

SMTC Corporation Debt increased on 5.4% while EBITDA decreased on 3.8%

SharpSpring, Inc. revenue growth accelerated from 21.7% in FY2019 to 29.0% in FY2020

Interlink Electronics, Inc. reports 8.1 pp EBITDA Margin growth from -2.3% to 5.9% in 2020 in 2020 while 5.7% Revenue decline

Intellicheck, Inc. Net Income jumped on 122% and Revenue jumped on 40.1%

VirnetX Holding Corp revenue jumped on 355,942% and EBITDA Margin surged on 23,179 pp from -23,127% to 52.2%

Twit about AMTX stock

Share your investment idea or question on Aemetis, Inc stock:

Latest twits on Aemetis, Inc (AMTX)

No twits yet. Be the first to post!

Have a question about AMTX? Ask and other investors will be eager to help you.

Have an idea about AMTX? Share it with other investors.

Aemetis, Inc news

03/11/2021 Aemetis, Inc reports 485% EBITDA decline in 2020 and almost no change in EBITDA Margin of -0.34%

Aemetis, Inc stock price chart

Aemetis, Inc financials

mln. $	FY2015	FY2016	FY2017

Revenue	146.6	143.2	150.2
EBITDA	-3.750	4.015	-7.169
Net income	-27.138	-15.636	-30.301
CAPEX	0.071	0.629	1.116
Debt	103.6	114.6	132.4
Cash	0.283	1.486	0.428

Aemetis, Inc news

03/11/2021 Aemetis, Inc reports 485% EBITDA decline in 2020 and almost no change in EBITDA Margin of -0.34%

About Aemetis, Inc

Aemetis, Inc. is a biotechnology company. The Company has engineered bacterium capable of converting whole plant materials into sugars that can then be used to make a range of commercially products in the biochemical and biofuels industries.